HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun-Jen Liu Selected Research

MT 12

1/2016Synergistic Combination of Multistage Magnetic Guidance and Optimized Ligand Density in Targeting a Nanoplatform for Enhanced Cancer Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun-Jen Liu Research Topics

Disease

17Neoplasms (Cancer)
11/2021 - 08/2002
9Hepatocellular Carcinoma (Hepatoma)
08/2021 - 01/2012
6Neoplasm Metastasis (Metastasis)
08/2021 - 12/2003
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 08/2021
3Colitis
09/2019 - 09/2013
3Inflammation (Inflammations)
09/2019 - 01/2016
2Lung Neoplasms (Lung Cancer)
05/2022 - 11/2021
2Lung Injury
01/2017 - 09/2013
2Sepsis (Septicemia)
01/2017 - 09/2012
2Leukemia
01/2016 - 08/2015
1Carcinogenesis
11/2021
1Liver Diseases (Liver Disease)
09/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2021
1Fibrosis (Cirrhosis)
09/2021
1Malnutrition (Nutritional Deficiencies)
08/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2019
1Edema (Dropsy)
08/2018
1Virus Diseases (Viral Diseases)
04/2018
1Asthma (Bronchial Asthma)
04/2018
1Glioblastoma (Glioblastoma Multiforme)
09/2015
1Glioma (Gliomas)
09/2015
1Gout
09/2015
1Colonic Neoplasms (Colon Cancer)
01/2015
1Prostatic Neoplasms (Prostate Cancer)
06/2014
1Pneumonia (Pneumonitis)
09/2013
1Diabetes Mellitus
04/2012
1Type 2 Diabetes Mellitus (MODY)
04/2012
1Stomach Neoplasms (Stomach Cancer)
09/2011

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
11/2021 - 02/2018
3Proteins (Proteins, Gene)FDA Link
11/2021 - 01/2016
3CytokinesIBA
09/2021 - 09/2013
3Folic Acid (Vitamin M)FDA LinkGeneric
08/2021 - 09/2015
3Dextran SulfateIBA
09/2019 - 09/2013
3Glutamine (L-Glutamine)FDA Link
01/2014 - 02/2011
2Docetaxel (Taxotere)FDA Link
05/2022 - 11/2021
2SurvivinIBA
11/2021 - 01/2012
2Ethanol (Ethyl Alcohol)IBA
11/2021 - 08/2018
2Fish OilsIBA
01/2017 - 03/2016
2Messenger RNA (mRNA)IBA
01/2016 - 09/2013
2LipopolysaccharidesIBA
01/2016 - 09/2013
2InterleukinsIBA
01/2015 - 09/2013
2Small Interfering RNA (siRNA)IBA
06/2014 - 09/2011
2alanylglutamineIBA
09/2013 - 09/2013
2AntioxidantsIBA
04/2012 - 02/2011
2Streptozocin (Streptozotocin)FDA Link
04/2012 - 02/2011
1CollagenIBA
09/2021
1TriterpenesIBA
09/2021
1Carbon Tetrachloride (Tetrachloromethane)IBA
09/2021
1ErbB Receptors (EGF Receptor)IBA
08/2021
1Tyrosine Kinase InhibitorsIBA
08/2021
1Chlorpyrifos (Lorsban)IBA
09/2019
1Irritants (Vesicants)IBA
04/2018
1Environmental Pollutants (Pollutants, Environmental)IBA
04/2018
1Thymic Stromal LymphopoietinIBA
04/2018
1Glutathione (Reduced Glutathione)IBA
04/2018
1Arsenic Trioxide (Trisenox)FDA Link
04/2018
1Glutamate-Cysteine LigaseIBA
04/2018
1Ligases (Synthetase)IBA
04/2018
1MicronutrientsIBA
06/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2017
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2016
1LigandsIBA
01/2016
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2016
1Conditioned Culture MediaIBA
01/2016
1MT 12IBA
01/2016
1ColchicineFDA LinkGeneric
09/2015
1TubulinIBA
09/2015
1Antimitotic AgentsIBA
09/2015
1dihydrotanshinone IIBA
08/2015
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
01/2015
1Insulin-Like PeptidesIBA
01/2015
1Hyaluronic Acid (Hyaluronan)IBA
01/2015
1Interleukin-6 (Interleukin 6)IBA
01/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015
1HydrogelsIBA
01/2015
1Transcription Factors (Transcription Factor)IBA
01/2015
1Biomarkers (Surrogate Marker)IBA
06/2014
1ThrombomodulinIBA
06/2014
1Hormones (Hormone)IBA
06/2014
1MicroRNAs (MicroRNA)IBA
12/2013
1SolutionsIBA
09/2013
1Biological ProductsIBA
09/2013
1AC133 AntigenIBA
09/2013
1shikoninIBA
08/2013
1salicylhydroxamic acid (SHAM)IBA
09/2012
1Polysaccharides (Glycans)IBA
09/2012
1Caseins (Casein)FDA Link
04/2012
1VimentinIBA
01/2012
1Endoplasmic Reticulum Chaperone BiPIBA
01/2012
1NicotineFDA Link
09/2011
1MitogensIBA
09/2011
1Cadherins (E-Cadherin)IBA
09/2011

Therapy/Procedure

4Therapeutics
05/2022 - 01/2016
2Drug Therapy (Chemotherapy)
05/2022 - 11/2021
2Injections
02/2018 - 01/2015
2Ligation
01/2017 - 09/2012
2Punctures
01/2017 - 09/2012
1Radiotherapy
04/2018
1Intravenous Administration
09/2015